You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IL17

Showing 1 - 25 of 5,224
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Axial Spondyloarthritis Trial in Nîmes, Montpellier, Tours (Daily dietary supplementation with Fibruline, Anti-IL-17 therapy)

Recruiting
  • Axial Spondyloarthritis
  • Daily dietary supplementation with Fibruline
  • Anti-IL-17 therapy
  • Nîmes, Gard, France
  • +2 more
Apr 19, 2023

COVID-19 Respiratory Infection Trial in Sohag (laboratory test)

Completed
  • COVID-19 Respiratory Infection
  • laboratory test
  • Sohag, Egypt
    Sohag University
Oct 24, 2022

Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Oct 4, 2022

    IL17 Rate and Spondyloarthritis

    Recruiting
    • Spondylarthritis
    • Blood sample
    • Nice, France
      CHU de NICE
    Oct 21, 2022

    Acne Vulgaris, Vitamin D Trial in Jakarta Pusat (combination oral and topical vitamin D, oral and topical cholecalciferol, oral

    Enrolling by invitation
    • Acne Vulgaris
    • Vitamin D
    • combination oral and topical vitamin D
    • +2 more
    • Jakarta Pusat, DKI Jakarta, Indonesia
      RSUPN Dr. Cipto Mangunkusumo
    Mar 4, 2023

    Host Microbiota and Il-17 in Favoring Multiple Myeloma

    Recruiting
    • Multiple Myeloma
      • Milan, Milano, Italy
        IRCCS Ospedale San Raffaele
      Jan 26, 2023

      Psoriasis Trial in Shanghai, Kunming (Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection, Placebo)

      Active, not recruiting
      • Psoriasis
      • Recombinant Anti-IL-17A Humanized Monoclonal Antibody Injection
      • Placebo
      • Shanghai, Shanghai, China
      • +2 more
      Nov 7, 2022

      Patients Receiving Biotherapies Targeting IL-23/IL-17 Axis in

      Recruiting
      • Psoriasis
      • Blood sample
      • +2 more
      • Paris, Ile De France, France
        Lars ROGGE
      Oct 6, 2022

      Long COVID, POTS - Postural Orthostatic Tachycardia Syndrome, Autonomic Dysfunction Trial (IL-6, cytokines (IL-17, and IFN-?),

      Not yet recruiting
      • Long COVID
      • +2 more
      • IL-6
      • +2 more
      • (no location specified)
      Sep 6, 2023

      Idiopathic Subglottic Stenosis Trial in New Haven (Taltz)

      Not yet recruiting
      • Idiopathic Subglottic Stenosis
      • New Haven, Connecticut
        Yale New Haven Hospital
      Jul 21, 2022

      Psoriasis, Psoriasis Vulgaris Trial in Gent, Nijmegen (Secukinumab, Ixekizumab, Brodalumab)

      Recruiting
      • Psoriasis
      • Psoriasis Vulgaris
      • Brussels, Belgium
      • +18 more
      Dec 5, 2022

      Psoriasis Vulgaris, UVB Phototherapy Burn Trial in Qina (Serum Interleukin 17 levels, NB-UVB)

      Completed
      • Psoriasis Vulgaris
      • UVB Phototherapy Burn
      • Serum Interleukin 17 levels
      • NB-UVB
      • Qinā, Qena, Egypt
        South Valley University
      Dec 9, 2022

      Psoriasis Trial in Shanghai (608 Q2W, 608 Q4W, Placebo)

      Not yet recruiting
      • Psoriasis
      • 608 Q2W
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Huanshan Hospital Fudan University
      Sep 8, 2022

      Obstructive Sleep Apnea and Idiopathic Pulmonary Fibrosis

      Recruiting
      • OSA，IPF
      • IL-17A,S100A8
      • Tianjin, China
        Tianjin Medical University General Hospital
      Apr 20, 2023

      Il-17 and Il-18 in Aggressive Periodontitis

      Completed
      • Aggressive Periodontitis
      • non surgical periodontal therapy
      • Cairo, Egypt
        Faculty of oral and dental medicine,FUE, Cairo,Egypt
      Mar 30, 2022

      Periodontitis Trial (No intervention was applied to the groups the samples will be collected in terms of the diagnosis

      Not yet recruiting
      • Periodontitis
      • No intervention was applied to the groups the samples will be collected in terms of the diagnosis (periodontitis, healthy)
      • (no location specified)
      Mar 31, 2022

      Axial Spondyloarthritis Trial in Besançon (Blood sample, anti-TNF antibody administration, anti-IL-17 antibody administration)

      Recruiting
      • Axial Spondyloarthritis
      • Blood sample
      • +2 more
      • Besançon, France
        Centre Hospitalier Universitaire de Besançon
      May 31, 2022

      IL17 in Systemic Lupus Erythematosus Patients: Association With

      Not yet recruiting
      • Systemic Lupus Erythematosus
      • Serum level of IL-17
      • Sohag, Egypt
        Sohag University Hospital
      Sep 12, 2021

      Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))

      Withdrawn
      • Primary Sjogren's Syndrome
      • tibulizumab (LY3090106)
      • Palo Alto, California
        Stanford University
      Jan 12, 2022

      IL-17, TNF-alpha, RANKL Levels in Gingival Cervicular Fluid

      Not yet recruiting
      • Apical Periodontitis
      • The teeth diagnosed with chronic apical periodontitis
      • (no location specified)
      Feb 1, 2022

      Periodontitis, Periodontal Diseases, Smoking Trial in Ankara (Non-surgical periodontal treatment)

      Completed
      • Periodontitis
      • +3 more
      • Non-surgical periodontal treatment
      • Ankara, Turkey
      • +1 more
      Mar 15, 2022

      Mouth Diseases, Periodontal Inflammation, Periodontal Diseases Trial in Antalya (GCF obtaining, Saliva Obtaining, Serum

      Completed
      • Mouth Diseases
      • +2 more
      • GCF obtaining
      • +2 more
      • Antalya, Turkey
        Akdeniz University Faculty of Dentistry
      Jun 29, 2022

      Autoimmune Disease Trial in Joondalup, Nedlands (SCT650C)

      Not yet recruiting
      • Autoimmune Disease
      • Joondalup, Western Australia, Australia
      • +2 more
      Jun 7, 2023

      IL-17+ CD8 T Cells in Cancer Patients Trial in Taichung

      Completed
      • IL-17+ CD8 T Cells in Cancer Patients
        • Taichung, Taiwan
          China Medical University Hospital
        Jul 27, 2021

        Plaque Psoriasis Trial (BAT2306, EU-approved Cosentyx)

        Recruiting
        • Plaque Psoriasis
        • Hangzhou, Zhejiang, China
          The Second Affiliated Hospital of Zhejiang University School of
        Jan 9, 2023